Nasdaq - Delayed Quote USD

BlackRock Health Sciences Opps K (SHSKX)

65.94
+0.52
+(0.79%)
As of 8:07:14 AM EDT. Market Open.

Performance Overview

Morningstar Return Rating --
YTD Return -4.48%
5y Average Return 5.18%
Number of Years Up 7
Number of Years Down 1
Best 1Y Total Return (May 15, 2025) 25.74%
Worst 1Y Total Return (May 15, 2025) --
Best 3Y Total Return 25.74%
Worst 3Y Total Return 0.74%

Trailing Returns (%) Vs. Benchmarks

Monthly Total Returns
SHSKX
Category
YTD
1.42%
7.95%
1-Month
-2.18%
4.81%
3-Month
-5.24%
7.18%
1-Year
1.54%
30.16%
3-Year
4.94%
16.10%
5-Year
6.94%
15.71%
10-Year
8.74%
15.27%
Last Bull Market
6.78%
23.06%
Last Bear Market
-5.90%
-13.88%

Annual Total Return (%) History

Year
SHSKX
Category
2025
--
--
2024
4.22%
--
2023
3.93%
--
2022
-5.60%
--
2021
12.19%
--
2020
19.91%
27.63%
2019
25.74%
26.23%
2018
8.39%
-0.40%

2017
25.30%
24.31%
2016
--
-10.60%

Past Quarterly Returns

YearQ1Q2Q3Q4
2025 3.68% -- -- --
2024 8.78% 0.79% 4.27% -8.83%
2023 -2.35% 4.41% -3.73% 5.89%
2022 -5.77% -5.90% -5.20% 12.31%
2021 0.20% 7.45% -2.28% 6.63%
2020 -11.45% 17.57% 6.44% 8.20%
2019 8.89% 1.97% -1.55% 15.03%
2018 0.12% 6.58% 13.01% -10.12%
2017 10.51% 7.99% 3.29% 1.65%
2016 2.78% -5.36% -- --

Rank in Category (By Total Return)

YTD 25
1-Month 72
3-Month 34
1-Year 32
3-Year 19
5-Year 31

Load Adjusted Returns

1-Year 1.54%
3-Year 4.94%
5-Year 6.94%
10-Year 8.74%

Performance & Risk

YTD Return -4.48%
5y Average Return 5.18%
Rank in Category (ytd) 25
% Rank in Category (ytd) --
Beta (5Y Monthly) 0.62
Morningstar Risk Rating

Fund Overview

Category Health
Fund Family BlackRock
Net Assets 6.91B
YTD Return 1.42%
Yield 0.40%
Morningstar Rating
Inception Date Oct 16, 2000

Fund Summary

The fund invests at least 80% of its total assets in equity securities, primarily common stock, of companies in health sciences and related industries. The health sciences sector can include companies in health care equipment and supplies, health care providers and services, biotechnology, and pharmaceuticals. It will concentrate its investments (i.e., invest more than 25% of its assets) in health sciences or related industries, and may invest in companies located in non-U.S. countries.

Related Tickers